Partner With Us To:
Raise Brand Awareness
Benefit from pre and post-conference exposure to our KOL TGF-beta community and increase market share through unique branding formats and interviews
Position Yourself as an Industry Expert
With the continual rise in outsourcing from both large pharma and biotech, this meeting is a dedicated platform to put your independent expertise in front of the key decision-makers in this rapidly growing field
Virtually Meet and Network with Industry Pioneers
With a “room” full of innovators looking to see how they can effectively advance their pipeline, meet prospective clients during virtual speed networking breaks, bespoke 1-2-1 meetings, and more informal networking receptions
Generate Commercial Collaborations
Make sure your hottest prospects are in the room and part of the discussion, by having a wish-list of your choice contacted in advance of the event.
Building on the success of anti-PD-1, PD-L1, and anti-CTLA4 therapies, TGFβ has shown promising potential to drug developers as the next blockbuster checkpoint combination for novel immuno-oncology treatment.
In this context, the innovators developing these therapeutics are looking for new solutions in the following areas:
- Preclinical Model Development
- Next-Generation Sequencing
- Biomarker Identifications
- Safety and Toxicology Testing
- Clinical Research